01/01/2023
Medice UK initiated in the UK
Medice are pleased to announce the initiation of Medice UK, the newest subsidiary of the European organisation.
Medice UK will be responsible for the management of Medice’s ADHD portfolio in the UK, and the launch of any future products released by Medice.
Medice UK replaces Flynn Pharma as our distribution partner for ADHD in the UK. Flynn Pharma have been a trusted and successful partner for Medice for over 10 years and have supported the transition with good grace and have our gratitude for this.
Adverse event reporting
Adverse events should be reported. Reporting forms and information can be found at the Yellow Card Scheme; https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should be reported to MEDICE UK at medicalinformation@medice.co.uk
Please retain the reported medication and packaging for further investigation by MEDICE UK.
Reporting side effects can provide more information on the safety of this medicine.
Adverse events should be reported. Reporting forms and information can be found at the Yellow Card Scheme; https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should be reported to MEDICE UK at medicalinformation@medice.co.uk
Please retain the reported medication and packaging for further investigation by MEDICE UK.
Reporting side effects can provide more information on the safety of this medicine.